British Journal of PharmacologyMore Press Releases related to this journal
The British Journal of Pharmacology is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. Its scope includes: molecular and cellular pharmacology, neuropharmacology, cardiovascular and pulmonary pharmacology, pharmacokinetics, drug metabolism, toxicology, gastrointestinal pharmacology, cancer pharmacology, inflammation and immunopharmacology, genitourinary and renal pharmacology, endocrine pharmacology, drug discovery, biopharmaceuticals and methods and techniques. BJP’s 2008 Impact Factor is 4.902 (Thomson Reuters Science Citation Index). The British Journal of Pharmacology can be accessed at www.brjpharmacol.org
The British Pharmacological Society is the professional association for pharmacologists in the UK and is one of the leading pharmacological societies in the world. The history of the Society originates in 1931 when a group of pharmacologists met in Oxford and decided to form a learned society. Since those small beginnings the Society has grown to exceed 2500 members and on 1 January 1994 the Society became a Company Limited by Guarantee. It is also a registered charity. The object of the Society is to promote and advance pharmacology, including clinical pharmacology. For more information, please visit www.bps.ac.uk.